Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of polycation carrier coated recombinant adenovirus to preparation of anti-tumor gene drug

A recombinant adenovirus and polycation technology, which can be used in anti-tumor drugs, gene therapy, drug combinations, etc., and can solve the problems of limited clinical application, toxic side effects and high cost.

Inactive Publication Date: 2018-04-20
KUNMING MEDICAL UNIVERSITY
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Due to the rapid renal clearance, it is still necessary to repeatedly inject large doses of IL-15 cytokines to achieve an effective therapeutic dose. The toxic side effects and high cost caused by this shock therapy also limit its wide clinical application.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of polycation carrier coated recombinant adenovirus to preparation of anti-tumor gene drug
  • Application of polycation carrier coated recombinant adenovirus to preparation of anti-tumor gene drug
  • Application of polycation carrier coated recombinant adenovirus to preparation of anti-tumor gene drug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0063] Packaging and expression of Adv-IL5:

[0064] The titer was measured by the TCID50 method:

[0065] Adv-IL5: The titer of the virus is (0.7×5×10 10.5 )PFU=1.106×10 11 PFU / mL

[0066] Adv–Luciferase: The titer of the virus is (0.7×5×10 10.41 )PFU=9.0×10 10 PFU / mL

[0067] Production and expression detection of H1 / Adv-IL15 In order to determine the optimal packaging ratio, we first used different ratios of H1 to package Adv-Luc. Such as image 3 Shown, H1:Adv-Luc=70nmol:2×10 6 pfu showed the highest transfection efficiency, therefore, this ratio was determined to be the optimal packaging ratio and used in future experiments.

[0068] Such as Figure 4 As shown, B16 cells were transduced with H1 / Adv-IL15, and IL-15 cells were highly expressed in the culture medium.

[0069] Such as Figure 5 Shown: Compared with the control group, Adv-IL15 and HI / Adv-IL15 treatment, the growth rate of the tumor volume was significantly reduced, indicating that the above treatmen...

Embodiment 2

[0073] HI / Adv-IL15 reduces pulmonary metastatic nodules of malignant melanoma and prolongs the survival time of tumor-bearing mice:

[0074] Such as Figure 7 Shown: Adv-Luc, H1 / Adv-Luc, Adv-IL15 and HI / Adv-IL15 treatment groups reduced the number of pulmonary nodules in mice, and the reduction in HI / Adv-IL15 treatment group was obvious and had statistical significance ( student t-t test, n=6, p<0.05).

[0075] Such as Figure 8 Shown: Adv-IL15 and HI / Adv-IL15 treatment groups prolong the survival time of metastatic tumor model mice.

Embodiment 3

[0077] HI / Adv-IL15 treatment increases the number of peripheral blood CD4+ T cells:

[0078] We used flow cytometry to detect the number of CD4+ T cells in peripheral blood lymphocytes. Representative flow cytometry histograms are shown in Figure 10 , the statistics show that Figure 9 , Compared with the control group HI / Adv-Luc, Adv-Luc, 5% Glu, HI / Adv-IL15, Adv-IL15 treatment significantly increased the number of peripheral blood CD4+ T cells (P<0.05).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of polycation carrier coated recombinant adenovirus to preparation of an anti-tumor gene drug. A polycation carrier is polycation formed by polymerizing cyclodextrin and polyethyleneimine folic acid; the anti-tumor gene drug is a gene drug obtained by transducing human-derived interleukin 15 on the recombinant adenovirus. H1 / rAdv-15 can be used for effectively inhibiting the growth of tumors on a subcutaneous and metastatic malignant melanoma mouse model, the survival time of a tumor-bearing mouse is prolonged and the curative effect is better than that of independent Adv-IL15. An anti-tumor mechanism of the H1 / rAdv-15 mainly has the effects of activating multiplication of CD4+ and CD8+T cells and NK (Natural Killer) cells, stimulating the killing activeof the cells and inhibiting an immunosuppression cell Treg to express the anti-tumor activity, so that a new thought is provided for immunization therapy of malignant melanoma.

Description

technical field [0001] The invention belongs to the technical field of application of anti-tumor drugs, and in particular relates to the application of a polycation carrier-coated recombinant adenovirus in the preparation of anti-tumor gene drugs. Background technique [0002] Cutaneous malignant melanoma (melanoma) is the most malignant tumor in skin cancer. Occur in Caucasians more often, in our country, the sickness rate of evil black is relatively low, but the sickness rate increases rapidly. With the advent of an aging society, some scholars have even suggested that malignant melanoma will become an important issue affecting public health in the next decade. Due to geographical and living habits and other factors, photodermatosis and chronic skin damage are more common in Yunnan Province, and the occurrence rate of dark spots is relatively high. [0003] Based on the immunogenic properties of malignant melanoma, immunotherapy has become an important adjuvant therapy f...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K48/00A61K38/20A61K47/40A61K47/34A61P35/00
CPCA61K38/2086A61K47/34A61K47/40A61K48/005
Inventor 姚宏张媛刘旭
Owner KUNMING MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com